← Back
$BTAI All transactions

BioXcel Therapeutics, Inc.

M

$ Value

Shares

625

Price

Filed

Jul 22

Insider

Name

Steinhart Richard I

Title

Chief Financial Officer

CIK

0001293789

Roles

Officer

Transaction Details

Transaction Date

2025-07-22

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

6,441

Footnotes

The Issuer previously granted the Reporting Person an award of restricted stock units that would vest based on the Issuer's satisfaction of certain performance objectives and subject to the Reporting Person's continued service with the Issuer through July 22, 2025 (the "PSUs"). On July 22, 2025, the Compensation Committee of the Issuer's Board of Directors determined that performance conditions with respect to 4,375 PSUs had been satisfied and 4,375 shares of common stock became issuable to the Reporting Person on July 22, 2025. | Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. | On July 22, 2024, the Reporting Person was granted 625 RSUs, which vested as to 100% of the total number of RSUs on the first anniversary of the grant date.

Filing Info

Accession No.

0001104659-25-069701

Form Type

4

Issuer CIK

0001720893

Steinhart Richard I's History

Date Ticker Type Value
2026-03-15 BTAI M
2026-03-15 BTAI M $0
2026-03-14 BTAI M
2026-03-14 BTAI M $0
2026-01-01 BTAI A $0
2025-12-15 BTAI M
2025-12-15 BTAI M $0
2025-12-14 BTAI M
2025-12-14 BTAI M $0
2025-09-15 BTAI M

Other Insiders at BTAI (90d)

Insider Bought Sold Last
Steinhart Richard I
Chief Financial Officer
2026-03-15
Yocca Frank
Chief Scientific Officer
2026-03-15
Mehta Vimal
CEO and President
2026-03-15
Rodriguez Javier
See Remarks
2026-03-15